Evidence map›Paper›PMID 33716969›Full record

ArticleFrontiers in endocrinology2021

The Combination of Sonographic Features and the Seven-Gene Panel May be Useful in the Management of Thyroid Nodules With Indeterminate Cytology.

Marco Capezzone, Silvia Cantara, Andrea Di Santo, Alfonso Sagnella, Tania Pilli, Lucia Brilli, Cristina Ciuoli, Fabio Maino, Raffaella Forleo, Alessandra Cartocci and 1 more

Open access · goldAbstract readEvaluation Study
In one paragraph

Article in Frontiers in endocrinology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 2 pooled it
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 2 syntheses or guidelines pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Marco CapezzoneDepartment of Medical, Surgical and Neurological Sciences, University of Siena, Siena, Italy.
Silvia CantaraDepartment of Medical, Surgical and Neurological Sciences, University of Siena, Siena, Italy.
Andrea Di SantoPathology Unit, University of Siena, Siena, Italy.
Alfonso SagnellaDepartment of Medical, Surgical and Neurological Sciences, University of Siena, Siena, Italy.
Tania PilliDepartment of Medical, Surgical and Neurological Sciences, University of Siena, Siena, Italy.
Lucia BrilliDepartment of Medical, Surgical and Neurological Sciences, University of Siena, Siena, Italy.
Cristina CiuoliDepartment of Medical, Surgical and Neurological Sciences, University of Siena, Siena, Italy.
Fabio MainoDepartment of Medical, Surgical and Neurological Sciences, University of Siena, Siena, Italy.
Raffaella ForleoDepartment of Medical, Surgical and Neurological Sciences, University of Siena, Siena, Italy.
Alessandra CartocciDepartment of Medical Biotechnologies, University of Siena, Siena, Italy.
Maria Grazia CastagnaDepartment of Medical, Surgical and Neurological Sciences, University of Siena, Siena, Italy.
University of Siena · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The management of patients with indeterminate thyroid nodules, which account for 10-25% of thyroid fine needle aspiration biopsies (FNABs), is still very challenging. Aim: To verify the utility of the seven-gene panel in combination with ultrasound features in the clinical management of indeterminate thyroid nodules. Results: The study group included 188 indeterminate thyroid nodules, divided into TIR3A (56.4%) and TIR3B (43.6%). A significant correlation between US categories and both cytological and molecular results was observed. In detail, TIR3B cytology was more frequent in EU-TIRADS 4 and 5 nodules (54.7 and 50%, respectively) than in EU-TIRADS 2 and 3 nodules (31%, Conclusions: US score seems able to correctly discriminate between TIR3A nodules in which a conservative approach may be used, and those in which additional test, such as molecular test, may be indicated. On the contrary, in TIR3B nodules both US risk stratification and seven-gene panel seem to be of little use, because the risk of thyroid cancer remains high regardless of US score and mutational status.

Indexed as

TranscriptomeAdolescentAdultAgedAged, 80 and overBiopsy, Fine-NeedleCytodiagnosisDiagnosis, DifferentialFemaleHumansMaleMiddle AgedMolecular Diagnostic TechniquesPredictive Value of TestsRetrospective StudiesThyroid Glandfine needle aspiration cytology (FNAC)indeterminate nodulesmolecular testthyroid nodulesthyroid ultrasound

Identifiers

PMID33716969
PMCPMC7943869
OpenAlexW3130139031

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.